CCS1477 clinical trials

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

This study is testing a new drug, CCS1477 (also called inobrodib), for people with certain blood cancers like lymphoma, myeloma, or leukaemia. It aims to see if the drug is safe, well-tolerated, and how it works in the body.